ACM
MDCO

Advent Capital Management’s Medicines Co MDCO Stock Holding History

Advent Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-15,000
Closed -$415K – 501
2014
Q4 		$415K Buy
+15,000
New +$372K 0.01% 410

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Advent Capital Management's MDCO Position: Q1 2015 in Review

Advent Capital Management sold out of Medicines Co (MDCO) in Q1 2015, closing a stake of 15,000 shares — an estimated $415K sold.

Advent Capital Management first reported a position in MDCO in Q4 2014 and held it in 1 quarter. The position peaked at $415K in Q4 2014. 184 funds tracked by Wall St. Rank hold MDCO as of Q1 2015.

  • Advent Capital Management reported no remaining Medicines Co position as of Q1 2015 after selling out during the quarter.
  • Advent Capital Management sold 15,000 Medicines Co shares in Q1 2015, an estimated $415K.
  • Advent Capital Management first reported a position in Medicines Co in Q4 2014 and held it in 1 quarter.
  • Advent Capital Management's Medicines Co position peaked at $415K in Q4 2014.
  • 184 funds tracked by Wall St. Rank held Medicines Co as of Q1 2015.

Based on Advent Capital Management's 13F filing for Q1 2015, filed 13 May 2015.